Fox David Morton 4

What Happened

• David Morton Fox, a director of MediWound Ltd. (MDWD), made three purchases on June 1, 2026, acquiring a total of 3,537 shares. The trades were: 1,730 shares at $14.22 ($24,609), 10 shares at $14.23 ($142), and 1,797 shares at $13.99 ($25,149), for a combined cost of $49,900. These are coded as purchases (P), which indicates open-market or private purchases rather than sales.

Key Details

• Transaction date: June 1, 2026 (reported on Form 4 filed June 2, 2026). Filing appears timely (next-day filing).
• Prices and counts: 1,730 @ $14.22; 10 @ $14.23; 1,797 @ $13.99. Total 3,537 shares for $49,900.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Footnotes of note:
  • F1: Some ordinary shares shown elsewhere consist of RSUs granted Mar 4, 2026 that vest 100% one year after grant.
  • F3: Options shown elsewhere were granted Mar 4, 2026 and vest 100% one year after grant.
  • F2: One row was included for informational purposes only (no transaction affected those securities).
• Transaction code: P = Purchase (open market or private purchase).

Context

• Purchases by insiders are often watched as a potential bullish signal since they put personal capital to work, but they are not proof of future performance and motivations are not disclosed.
• The filing also references recently granted RSUs and options (Mar 4, 2026) that vest in one year; those grants are separate and were not exercised or sold in these reported transactions.